N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide

C27H21BrCl2N4O3 — CID 155285434

IUPACN-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide
SMILESO=C(NCc1ccccc1)c1c2n(c(=O)n1-c1cccc(Cl)c1)CCN(C(=O)c1ccc(Br)c(Cl)c1)C2
InChIInChI=1S/C27H21BrCl2N4O3/c28-21-10-9-18(13-22(21)30)26(36)32-11-12-33-23(16-32)24(25(35)31-15-17-5-2-1-3-6-17)34(27(33)37)20-8-4-7-19(29)14-20/h1-10,13-14H,11-12,15-16H2,(H,31,35)
InChIKeyOREBMRULQRWSDM-UHFFFAOYSA-N
MW600.30 g/mol
LogP5.29
Rot. Bonds5

About N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide

N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide (PubChem CID 155285434) has the molecular formula C27H21BrCl2N4O3 and a molecular weight of 600.30 g/mol. Its IUPAC name is N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide.

Molecular Properties

Compound NameN-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide
PubChem CID155285434
Molecular FormulaC27H21BrCl2N4O3
Molecular Weight600.30 g/mol
Exact Mass598.02
IUPAC NameN-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide
SMILESO=C(NCc1ccccc1)c1c2n(c(=O)n1-c1cccc(Cl)c1)CCN(C(=O)c1ccc(Br)c(Cl)c1)C2
InChIInChI=1S/C27H21BrCl2N4O3/c28-21-10-9-18(13-22(21)30)26(36)32-11-12-33-23(16-32)24(25(35)31-15-17-5-2-1-3-6-17)34(27(33)37)20-8-4-7-19(29)14-20/h1-10,13-14H,11-12,15-16H2,(H,31,35)
InChIKeyOREBMRULQRWSDM-UHFFFAOYSA-N
XLogP5.29
TPSA76.34 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500600.30
LogP ≤ 55.29
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide?
The IUPAC name of N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide (CID 155285434) is N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide.
What is the SMILES notation for N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide?
The canonical SMILES for N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide is O=C(NCc1ccccc1)c1c2n(c(=O)n1-c1cccc(Cl)c1)CCN(C(=O)c1ccc(Br)c(Cl)c1)C2.
What is the InChIKey of N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide?
The InChIKey is OREBMRULQRWSDM-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H21BrCl2N4O3/c28-21-10-9-18(13-22(21)30)26(36)32-11-12-33-23(16-32)24(25(35)31-15-17-5-2-1-3-6-17)34(27(33)37)20-8-4-7-19(29)14-20/h1-10,13-14H,11-12,15-16H2,(H,31,35).
What are the key properties of N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide?
N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide has a molecular weight of 600.30 g/mol, XLogP of 5.29, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-benzyl-7-(4-bromo-3-chlorobenzoyl)-2-(3-chlorophenyl)-3-oxo-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxamide is sourced from PubChem (CID 155285434), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).